Company / Interest Expense
Adaptive Biotechnologies Corp Interest Expense History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$11.8M
FY2025
5-year range
$4.2M / $13.8M
FY2022-FY2025
Trend
+1.7%
vs FY2024
Sector context
#25 of 44
Health Care
What the data says
At $12M, Adaptive Biotechnologies Corp's interest expense ranks #20 of 44 in the Health Care sector. Improved from $14M to $12M over the past 2 years.
Based on SEC 10-K filings.
$12M in FY2025 with a 3-year CAGR of +40.6%.
Improved from $14M to $12M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +40.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#20 of 44 in Health CareTop 43% of 44This company $11.8M Sector average $291.0M
▼
-96.0% below sector average
Key checks
Key Insights
- 3-year CAGR of +40.6%, indicating consistent growth.
- In FY2025, interest expense increased 1.7% year-over-year.
- Ranks #25 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.8M | +1.7% |
| FY2024 | $11.6M | -16.1% |
| FY2023 | $13.8M | +225.6% |
| FY2022 | $4.2M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026